PeptideSkincare
Skincare Fundamentals

Sunscreen for Melasma: Why Tinted, Iron Oxide Formulas May Matter

By · Published November 6, 2026 · Updated November 5, 2026 · 14 min read

Start with our pillar guide: What Is the Skin Barrier? The Science of Hydration, Ceramides and Occlusives, or browse all Skincare Fundamentals articles.

Daily broad-spectrum sunscreen for melasma is part of every care plan, but regular SPF mainly blocks UV. Visible light can also darken pigment, especially in medium to deep skin, and research suggests a sunscreen blocks it only if it's visibly tinted, usually with iron oxides. One trial favored iron-oxide sunscreen alongside a lightening cream. A later company-funded trial found no difference in melasma scores. Evidence: Limited.

Many search results say tinted sunscreen is essential for melasma. The research is more mixed. Only 2 trials we found scored melasma itself with numbers, and they disagree. Below we cover why visible light matters, what iron oxides in sunscreen do, what the trials show and how to choose a sunscreen for melasma by criteria, not product picks. Where the record says who paid for a study, we tell you.

Key takeaways

  • In a 61-person trial where everyone also used hydroquinone, an iron-oxide sunscreen that covered visible light led to 15% greater improvement in melasma scores than a UV-only sunscreen (Castanedo-Cazares et al., 2014).
  • A 2025 trial funded by a sunscreen maker found melasma scores fell with both tinted and untinted sunscreen, with no significant difference (Polena et al., 2025).
  • A sunscreen has to be visible on the skin to block visible light. Tints use iron oxides and pigment-grade titanium dioxide (Lyons et al., 2021).
  • There is no agreed standard test for visible light protection, so no label can promise a number (Lim et al., 2026).
  • Sunscreen protects. It is not a melasma treatment on its own (Passeron et al., 2026).

What is the best sunscreen for melasma? The short answer

The best sunscreen for melasma is not one product. It's a set of features. Expert reviews point to a broad-spectrum sunscreen with high SPF, good long-wave UVA coverage and a tint that blocks visible light, in a shade that matches your skin (Morgado-Carrasco et al., 2022). That review's authors have ties to a sunscreen maker: three consult for ISDIN and two are ISDIN employees. Evidence: Expert opinion.

The trial support for the tinted part is thin. One trial favored a tinted, iron-oxide formula, and a later one found no difference in melasma scores. So a tinted sunscreen for melasma is a reasonable choice that may help, not a sure bet. Whatever you choose, wearing it every day matters more than any single feature. Evidence: Limited.

Why does melasma need more than regular sunscreen?

Regular sunscreens are built to block ultraviolet (UV) light, but melasma seems to respond to more than UV. A review on melasma photoprotection says visible light, "in particular high-energy visible light (HEVL), and long-wave UVA (UVA1) play a key role in melasma" (Morgado-Carrasco et al., 2022). The same ISDIN ties noted above apply. Evidence: Expert opinion.

An expert panel on photoprotection by skin type wrote that "darker skin ... is more prone to hyperpigmentation induced by visible light (VL) and UVA" (Passeron et al., 2021). The full text says La Roche-Posay (part of L'Oréal) sponsored that meeting, and the authors report fees from La Roche-Posay, L'Oréal, ISDIN, Beiersdorf, Bioderma and other companies. Evidence: Expert opinion.

Human studies back up the idea, though they are small:

  • In 20 volunteers with skin types IV to VI, visible light caused pigment that "was darker and more sustained" than pigment from long-wave UVA. "No pigmentation was observed in skin type II" (Mahmoud et al., 2010). The study had non-US government support. PubMed doesn't state conflicts of interest. Evidence: Limited.
  • In 16 people grouped by skin tone, the response to visible light differed with natural melanin levels (Lim et al., 2023). A grant from L'Oréal USA funded that study. Evidence: Limited.
  • In a pilot study on skin samples from fair skin types, blue and green light stimulated melanin production even in type I skin (Moreiras et al., 2021). That was lab work, not people. It had non-US government support. PubMed doesn't state conflicts of interest, but two coauthors list Walgreens Boots Alliance as an affiliation. Evidence: Lab only.

A 2026 international consensus of light experts agreed that visible light contributes to dark marks after inflammation and plays "a role in melasma" (Lim et al., 2026). PubMed doesn't state its funding or conflicts, but Europe PMC lists a grant from Beiersdorf AG, a skincare and sunscreen maker. Research suggests melasma care should account for visible light and long-wave UVA as well as UV, though it doesn't show how much each one adds. Evidence: Expert opinion.

Does a tinted sunscreen for melasma help? What the trials show

Only 2 trials in our search scored melasma with numbers.

The 2014 trial (Mexico). 68 people with melasma were randomly assigned to one of 2 sunscreens for 8 weeks, and 61 finished. One sunscreen contained iron oxide and protected against UV and visible light. The other protected against UV only. Both were SPF 50 or higher. Everyone also used hydroquinone, a prescription lightening cream. The iron-oxide group had "15%, 28% and 4% greater improvements" in melasma scores (MASI), skin color readings and melanin in biopsies (Castanedo-Cazares et al., 2014). The study had non-US government support. PubMed doesn't state conflicts of interest. It's one small trial in intense sun, and it tested sunscreen alongside treatment, not alone. Evidence: Limited.

The 2015 relapse trial (France). A randomized trial looked at preventing melasma relapses with a sunscreen that protects against UV and short-wavelength visible light (Boukari et al., 2015). It was published as a research letter with no abstract, so we can't report its size or results. It had non-US government support. PubMed doesn't state conflicts, and one coauthor lists Laboratoire Bioderma (part of NAOS), a sunscreen maker, as an affiliation. Evidence: Limited.

The 2025 summer trial (France). 42 people enrolled and 41 finished a 5-month summer study comparing a tinted sunscreen that protects against visible light with an untinted one. In the full text, the modified melasma score (mMASI) fell in both groups: from 4.0 to 3.5 with tinted and from 4.1 to 3.2 with untinted, "without significant difference between them." Some skin color readings favored the tinted product (Polena et al., 2025). NAOS, a sunscreen maker, funded this trial. Three authors are or were NAOS employees, and one author reports honoraria from Beiersdorf, Galderma, L'Oréal, ISDIN, Pierre Fabre and others. Evidence: Limited.

The 2025 foundation study (US). Women with skin types III to VI used SPF 50 alone or SPF 50 plus an iron-oxide foundation for 12 weeks. Both groups improved. In the melasma subgroup, "36% of melasma participants in the SPF50+FeO group showed superior improvement in ... radiance (L) vs 0% in the SPF50 group" (Grimes et al., 2025). The study tested a foundation worn over sunscreen. The result comes from a subgroup, and the abstract doesn't give the group size. PubMed doesn't state the funding or the sponsor. Evidence: Limited.*

Study What was compared Melasma result Who paid / ties Evidence label
Castanedo-Cazares 2014, 61 completed Iron-oxide UV + visible light sunscreen vs UV-only, both with hydroquinone 15% greater MASI gain with iron oxide Non-US government support; COI not stated Limited
Boukari 2015, n not in PubMed UV + short-wavelength visible light sunscreen for relapse prevention Not reported (no abstract) Non-US government support; COI not stated Limited
Polena 2025, 41 completed Tinted vs untinted sunscreen, 5 summer months mMASI fell in both, no significant difference Funded by NAOS; NAOS employee authors Limited
Grimes 2025, n not in abstract SPF 50 vs SPF 50 + iron-oxide foundation Radiance gain in 36% vs 0% of melasma subgroup Not stated in PubMed Limited

Bottom line: the benefit of a tinted sunscreen for melasma looks modest and mixed. The best support comes from one trial where tint was added to a prescription cream. A 2025 trial funded by a sunscreen maker found melasma scores dropped about the same either way. Evidence: Limited.

What do iron oxides in sunscreen do for melasma?

Iron oxides are mineral pigments, the same kind of colorant used in cosmetics. In a sunscreen they add tint, and the tint is what lets it block visible light.

A review of tinted sunscreens lays out the key points (Lyons et al., 2021):

  • Broad-spectrum sunscreens protect against UV but "do not adequately protect against visible light."
  • "For a sunscreen to protect against visible light, it must be visible on the skin."
  • Zinc oxide and titanium dioxide are usually used as nanoparticles to avoid a white cast, and "as such, they do not protect against visible light."
  • Tinted sunscreens use "iron oxides and pigmentary titanium dioxide," mixed in different amounts to make different shades.

PubMed doesn't state funding or conflicts for that review, and one coauthor lists an affiliation with ISDIN, a sunscreen maker. Evidence: Expert opinion.

So an iron oxide sunscreen is, in practice, a tinted sunscreen. Tint has to cover your skin evenly to work, which is why shade matching matters.

There's a catch. A 2026 consensus says "no standard methods have been agreed upon for assessing VL photoprotection" (Lim et al., 2026). On US labels, the SPF number and the "broad spectrum" wording describe UV protection, not visible light. So no label can give you a reliable visible light number, and there's no shared test to check a "blue light protection" claim against. Evidence: Expert opinion.

Is mineral sunscreen for melasma better than chemical?

Not on its own. For visible light, the tint matters, not whether the UV filters are mineral or chemical. A clear mineral sunscreen with nano-sized zinc oxide or titanium dioxide doesn't block visible light (Lyons et al., 2021). A tinted mineral sunscreen adds iron oxides, but tinted formulas with chemical filters can too. We compare chemical and mineral sunscreen in our chemical vs mineral sunscreen guide. Evidence: Expert opinion.

How do you choose a sunscreen for melasma?

No trial we found compares specific products for melasma, so this checklist comes from expert reviews. It answers "best sunscreen for melasma" with criteria, not picks. Evidence: Expert opinion.

  • Broad spectrum. You need UVA coverage, including long-wave UVA, not just UVB (Morgado-Carrasco et al., 2022).
  • High SPF. Reviews on melasma recommend a high SPF, and the iron-oxide trial used SPF 50 or higher. Our guide to SPF 30 vs 50 explains the numbers.
  • Tinted, usually with iron oxides. If visible light is a concern, check the ingredient list for iron oxides.
  • A shade that matches. Tint only works if you wear enough of it, and a poor match makes that hard. A 2024 letter titled "Challenges of tinted sunscreen in skin of color" raised this issue (Xue et al., 2024). It has no abstract, and PubMed doesn't state its funding. A 2026 global consensus also flagged "the challenges of tinted sunscreen availability in diverse populations" (Passeron et al., 2026). A Beiersdorf grant funded that consensus, and the lead author reports honoraria from many companies.
  • A texture you'll wear daily. The ISDIN-linked review says melasma sunscreens should be cosmetically acceptable and leave no white residue. A broader review also covers choosing sunscreen for skin of color (Abdel Azim et al., 2025). One of its authors has consulted for Estée Lauder, and another for AbbVie and others.

How should you wear sunscreen for melasma?

A melasma review notes that most people with melasma don't fully follow sun protection advice (Morgado-Carrasco et al., 2022). Habits matter as much as the formula.

  • Apply every morning to the whole face, not just the patches, and spread tint evenly.
  • Reapply when you're outside for long stretches. Our guide on how often to reapply sunscreen covers timing and reapplying over makeup.
  • Layer in the right order. See whether sunscreen goes before or after moisturizer.
  • Makeup as an extra layer. In one study, an iron-oxide foundation worn over SPF 50 improved radiance in some people with melasma (Grimes et al., 2025). It's one study with a subgroup result, so treat foundation as an option, not a must. Evidence: Limited.

Can sunscreen alone treat melasma?

No study we reviewed showed that sunscreen clears melasma on its own. In the trial that favored iron-oxide sunscreen, everyone also used a lightening cream (Castanedo-Cazares et al., 2014). In the 2025 trial, melasma scores fell by less than 1 point in both groups (Polena et al., 2025). Evidence: Limited.

A 2026 global consensus on pigment disorders puts "special emphasis" on broad-spectrum photoprotection. Its treatment options range from topical lightening agents and oral tranexamic acid to chemical peels and lasers (Passeron et al., 2026). A Beiersdorf grant funded that project. The right treatment depends on your skin type, how deep the pigment is and your history, so ask your clinician. Evidence: Expert opinion.

For background, see our guides to tranexamic acid for skin and whether vitamin C helps with hyperpigmentation. The vitamin C guide also explains the MASI score.

What if you have sensitive skin and melasma?

A sunscreen that stings won't get worn, and you need to wear it every day for it to help. Tinted formulas differ in their filters and other ingredients, so the right one depends on what your skin tolerates, not on tint alone. Our guide to sunscreen for sensitive skin covers how to choose filters for skin that reacts easily. If a sunscreen burns, itches or causes a rash, stop using it and ask your clinician. Evidence: Expert opinion.

Where the evidence stops

  • Only 2 trials we found scored melasma with numbers, and they disagree on whether tint helps.
  • The trial favoring iron-oxide sunscreen tested it alongside hydroquinone, not alone.
  • Sunscreen makers funded or helped write much of this research.
  • There is no agreed standard test for visible light protection, so labels can't promise a number.
  • In the abstracts we reviewed, we didn't find melasma trials of indoor sunscreen use or of different filter types.

FAQ

What kind of sunscreen is best for melasma?

Expert reviews suggest a broad-spectrum sunscreen with a high SPF that is also tinted, usually with iron oxides, because tint is what blocks visible light. The shade should match your skin, and the texture should be one you will wear every day. The trial evidence for tint is mixed, so treat these as criteria rather than a guarantee.

Does tinted sunscreen help melasma?

It may. In one 61-person trial, an iron-oxide sunscreen improved melasma more than a UV-only sunscreen when both groups also used hydroquinone. A later trial funded by a sunscreen maker found melasma scores fell about equally with tinted and untinted sunscreen. A foundation study showed a benefit on skin brightness in a subgroup only.

Why do iron oxides matter in sunscreen?

A review of tinted sunscreens says a sunscreen must be visible on the skin to protect against visible light. Iron oxides, together with pigment-grade titanium dioxide, provide that tint. In one study of people with skin types IV to VI, visible light caused darker and longer-lasting pigment than long-wave UVA.

Is mineral sunscreen better for melasma?

Not by itself. The same review notes that nano-sized zinc oxide and titanium dioxide, the forms used in most clear mineral sunscreens, do not protect against visible light. What matters for visible light is tint, not whether the UV filters are mineral or chemical.

Does visible light make melasma worse?

Research suggests it plays a role. An international expert consensus says visible light plays a role in melasma, and small human studies show it can darken skin, especially in medium to deep skin tones. There is still no agreed standard test for how well a sunscreen blocks visible light.

Can sunscreen alone clear melasma?

We found no evidence that sunscreen clears melasma on its own. In the trial that favored iron-oxide sunscreen, everyone also used a lightening cream. Melasma treatment options such as topical lighteners, tranexamic acid, peels or lasers are chosen with a clinician, so ask your clinician.

Do I need sunscreen indoors for melasma?

The evidence is limited. We didn't find a trial that tested indoor sunscreen use for melasma in the abstracts we reviewed. One foundation study's authors described benefits indoors and outdoors, but the study didn't compare indoor settings. Ask your clinician how your daily light exposure fits your plan.

What SPF should I use for melasma?

Reviews on melasma recommend a broad-spectrum sunscreen with a high SPF, and the main iron-oxide trial used SPF 50 or higher in both groups. Our guide on SPF 30 vs 50 explains what those numbers mean. SPF describes UV protection and doesn't rate visible light. Ask your clinician what fits your skin and sun exposure.

References

  1. Castanedo-Cazares JP, et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014. Double-blind RCT, 68 randomized, 61 completed; non-US government support, COI not stated in PubMed. https://pubmed.ncbi.nlm.nih.gov/24313385/
  2. Polena H, et al. Comparison of Visible Light-Protective Tinted Sunscreen to Untinted Sunscreen to Protect Melasma Patients During Summer: A Prospective Randomized Investigator-Blinded Study. J Cosmet Dermatol. 2025. Prospective randomized investigator-blinded study, 42 enrolled, 41 completed; funded by NAOS, 3 authors are or were NAOS employees, 1 author reports honoraria from Beiersdorf, Galderma, L'Oréal, ISDIN, Pierre Fabre and others. https://pubmed.ncbi.nlm.nih.gov/41014037/
  3. Lyons AB, et al. Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens. J Am Acad Dermatol. 2021. Review; funding and COI not stated in PubMed (1 coauthor lists an ISDIN affiliation). https://pubmed.ncbi.nlm.nih.gov/32335182/
  4. Lim HW, et al. International modified Delphi consensus statement on visible light photoprotection: Effects, measurement, and recommendations. J Invest Dermatol. 2026. Modified Delphi consensus, 27 statements; funding and COI not stated in PubMed; Europe PMC lists a Beiersdorf AG grant. https://pubmed.ncbi.nlm.nih.gov/42101389/
  5. Passeron T, et al. Global consensus on the management of melanin hyperpigmentation disorders. J Eur Acad Dermatol Venereol. 2026. Delphi consensus, 10 experts; Beiersdorf grant, lead author reports honoraria from many companies. https://pubmed.ncbi.nlm.nih.gov/41362125/
  6. Morgado-Carrasco D, et al. Melasma: The need for tailored photoprotection to improve clinical outcomes. Photodermatol Photoimmunol Photomed. 2022. Narrative review; 3 authors consult for ISDIN, 2 are ISDIN employees. https://pubmed.ncbi.nlm.nih.gov/35229368/
  7. Passeron T, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021. Expert panel recommendations; meeting sponsored by La Roche-Posay (L'Oréal), authors report fees from La Roche-Posay, L'Oréal, ISDIN, Beiersdorf, Bioderma and others. https://pubmed.ncbi.nlm.nih.gov/33764577/
  8. Mahmoud BH, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010. Human irradiation study, 20 volunteers with skin types IV to VI plus skin type II; non-US government support, COI not stated in PubMed. https://pubmed.ncbi.nlm.nih.gov/20410914/
  9. Lim HG, et al. Skin type specific photobiological response to visible light is mediated by constitutional melanin. Photodermatol Photoimmunol Photomed. 2023. Human study, 16 participants; L'Oréal USA grant. https://pubmed.ncbi.nlm.nih.gov/36208217/
  10. Moreiras H, et al. Visible light and human skin pigmentation: The importance of skin phototype. Exp Dermatol. 2021. Pilot lab study on skin histocultures (types I to III); non-US government support, COI not stated in PubMed; two coauthors list Walgreens Boots Alliance as an affiliation. https://pubmed.ncbi.nlm.nih.gov/34081365/
  11. Boukari F, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015. Randomized comparative trial (research letter, no abstract; n not in PubMed); non-US government support, COI not stated in PubMed; one coauthor lists Laboratoire Bioderma (NAOS) as an affiliation. https://pubmed.ncbi.nlm.nih.gov/25443629/
  12. Grimes PE, et al. Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage. J Drugs Dermatol. 2025. 12-week comparative study, women with skin types III to VI, n not in abstract; funding and COI not stated in PubMed. https://pubmed.ncbi.nlm.nih.gov/40627587/
  13. Xue GR, et al. Challenges of tinted sunscreen in skin of color. Int J Dermatol. 2024. Letter, no abstract; funding and COI not stated in PubMed. https://pubmed.ncbi.nlm.nih.gov/39215428/
  14. Abdel Azim S, et al. Sunscreens part 1: Mechanisms and efficacy. J Am Acad Dermatol. 2025. Review; 1 author consulted for Estée Lauder, another for AbbVie and others. https://pubmed.ncbi.nlm.nih.gov/38772426/

For educational purposes only; not medical advice. See our disclaimer and research method.